Sfoglia per AUTORE
RIMASSA L
Collezione AOU San Luigi di Orbassano

  

Items : 8

Synaptophysin expression in (V600EBRAF-)mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Mar;146:145-154. doi: 10.1016/j.ejca.2021.01.016. Epub 2021 Feb 16.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Loupakis F; Dei Tos AP; Di Maio M; Zagonel V; Lonardi S; Biason P; Borga C; Centonze G; Santini D; Salmaso R; Salvatore L; Aprile G; Calvetti L; Smiroldo V; Rimassa L; Cortiula F; De Maglio G; Morano F; Boccaccino A; Bergamo F; Volante M; Zichi C; Dell'Aquila E; Sperti E; Pella N; Pietrantonio F; Schirripa M; Cremolini C; Maddalena G; et alii...

Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma. in Liver cancer / Liver Cancer. 2021 Jul;10(4):370-379. doi: 10.1159/000515551. Epub 2021 Jun 15.

2021
AOU San Luigi di Orbassano

Tovoli F; Dadduzio V; De Lorenzo S; Rimassa L; Masi G; Iavarone M; Marra F; Garajova I; Brizzi MP; Daniele B; Trevisani F; Messina C; Di Clemente F; Pini S; Cabibbo G; Granito A; Rizzato MD; Zagonel V; Brandi G; Pressiani T; Federico P; Vivaldi C; Bergna I; Campani C; Piscaglia F;

Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2021 Jul;29(7):3971-3980. doi: 10.1007/s00520-020-05972-2. Epub 2021 Jan 3.

2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

de Braud F; Di Bartolomeo M; Pietrantonio F; Randon G; Prisciandaro M; Ambrosini M; Pagani F; Niger M; Antista M; Longarini R; Cinieri S; Giordano M; Antonuzzo L; Petrelli F; Toscano G; Tomasello G; Zaniboni A; Clavarezza M; Murialdo R; Tampellini M; Racca P; Amatu A; Rimassa L; Antoniotti C; Morano F; Lonardi S; Corallo S; Raimondi A;

Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Feb;144:31-40. doi: 10.1016/j.ejca.2020.11.017. Epub 2020 Dec 13.

2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pietrantonio F; Morano F; Calareso G; Di Bartolomeo M; de Braud F; Vaiani M; Greco FG; Prisciandaro M; Pagani F; Palermo F; Raimondi A; Antista M; Clavarezza M; Racca P; Tomasello G; Murialdo R; Tampellini M; Zaniboni A; Smiroldo V; Antoniotti C; Bergamo F; Rimassa L; Lonardi S; Cremolini C; Randon G; Corallo S; Manca P;

Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Aug;135:230-239. doi: 10.1016/j.ejca.2020.04.048. Epub 2020 Jul 2.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pietrantonio F; Di Bartolomeo M; Peverelli G; de Braud F; Antista M; Niger M; Bergamo F; Cinieri S; Longarini R; Giordano M; Antonuzzo L; Petrelli F; Adamo V; Tomasello G; Zaniboni A; Clavarezza M; Murialdo R; Tampellini M; Ritorto G; Sartore-Bianchi A; Rimassa L; Antoniotti C; Corallo S; Lonardi S; Morano F; Raimondi A; Di Maio M; Raimondi A; Di Maio M; et alii...

The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials. in British journal of cancer / Br J Cancer. 2020 Aug;123(3):403-409. doi: 10.1038/s41416-020-0894-7. Epub 2020 May 19.

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Tonini G; Adamo V; Loupakis F; Tomasello G; Zaniboni A; Murialdo R; Boccaccino A; Claravezza M; Bustreo S; Tampellini M; Borelli B; Sartore-Bianchi A; Rimassa L; Lonardi S; Marmorino F; Corallo S; Moretto R; Morano F; Antoniotti C; Guarini V; Fucà G; Cortesi E; de Braud F; Cremolini C; Pietrantonio F; Fucà G; Guarini V; Antoniotti C; Morano F; et alii...

Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. in JAMA oncology / JAMA Oncol. 2019 Sep 1;5(9):1268-1275. doi: 10.1001/jamaoncol.2019.1467.

2019
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Longarini R; Petrelli F; Giordano M; Tomasello G; Adamo V; Zaniboni A; Murialdo R; Smiroldo V; Niger M; Antista M; Caporale M; Berenato R; Clavarezza M; Racca P; Tampellini M; Sartore-Bianchi A; Bergamo F; Rimassa L; Cremolini C; Raimondi A; Lonardi S; Miceli R; Corallo S; Pietrantonio F; Morano F; Cinieri S; Falcone A; Zagonel V; Di Bartolomeo M; et alii...

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial. in BMC cancer / BMC Cancer. 2019 Mar 29;19(1):283. doi: 10.1186/s12885-019-5498-3.

2019
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ciuffreda L; Basso M; Catalano V; Bracarda S; Verusio C; Maiello E; Cinieri S; Giuliani F; Tassinari D; Frassineti GL; Spallanzani A; Bonetti A; Tortora G; Scagliotti G; Pinotti G; Tomasello G; Bertolini A; Zaniboni A; Longarini R; Luporini AG; Rimassa L; Di Costanzo F; Cardellino GG; Scartozzi M; Berardi R; Di Donato S; Lonardi S; Tamberi S; Antista M; et alii...